Statin Use Reduces Risk of Progression of Liver Fibrosis, Among Patients With Chronic Hepatitis C: Analysis of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

被引：0
|
作者：
Simon, Tracey G.
King, Lindsay Y.
Zheng, Hui
Chung, Raymond T.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1026
引用
收藏
页码：S966 / S966
页数：1
相关论文
共 50 条
  • [41] Long-term antiviral treatment for recurrent hepatitis C after liver transplantation
    Bertuzzo, Valentina Rosa
    Cescon, Matteo
    Morelli, Maria Cristina
    Di Gioia, Paolo
    Tame, Mariarosa
    Lorenzini, Stefania
    Andreone, Pietro
    Ercolani, Giorgio
    Del Gaudio, Massimo
    Ravaioli, Matteo
    Cucchetti, Alessandro
    Dazzi, Alessandro
    D'Errico-Grigioni, Antonietta
    Pinna, Antonio Daniele
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (10) : 861 - 867
  • [42] RATE OF PROGRESSION OF HEPATIC FIBROSIS IN PATIENT WITH CHRONIC HEPATITIS C (CHC) PREDICTS NON-HCC AND HCC OUTCOMES: RESULTS FROM THE HALT-C TRIAL
    Hoofs, John C.
    Shiffman, Mitchell L.
    Goodman, Zachary
    Kleiner, David E.
    Stoddard, Anne M.
    Dienstag, Jules L.
    HEPATOLOGY, 2010, 52 (04) : 412A - 412A
  • [43] The spectrum of hepatic functional impairment in compensated chronic hepatitis C: results from the hepatitis C anti-viral long-term treatment against cirrhosis trial
    Everson, G. T.
    Shiffman, M. L.
    Morgan, T. R.
    Hoefs, J. C.
    Sterling, R. K.
    Wagner, D. A.
    Kulig, C. C.
    Curto, T. M.
    Wright, E. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (09) : 798 - 809
  • [44] Noninvasive Diagnosis of Liver Fibrosis and Cirrhosis in Chronic Hepatitis C Patients
    Attallah, Abdelfattah M.
    El-Far, Mohamed
    Omran, Mohamed M.
    Farid, Khaled
    Albannan, Mohamed S.
    El-Dosoky, Ibrahim
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2013, 27 (02) : 121 - 129
  • [45] Hepatic function improves after sustained virologic response in hepatitis C patients with advanced fibrosis and cirrhosis: Results of the lead-in phase of the HALT-C trial
    Everson, GT
    Shiffman, M
    Sterling, RK
    Hoefs, JC
    Morgan, T
    DeSanto, J
    Lauriski, S
    Shea, S
    Hofmann, C
    Rietkerk, W
    Milne, N
    Wright, E
    Doherty, M
    HEPATOLOGY, 2005, 42 (04) : 697A - 697A
  • [46] Long-term Effect of Antiviral Treatment on the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
    Lee, Yun Bin
    Nam, Joon Yeul
    Lee, Jeong-Hoon
    Chang, Young
    Cho, Hyeki
    Cho, Young Youn
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Hwi Young
    Lee, Dong Ho
    Lee, Jeong Min
    Hwang, Seong-Gyu
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2017, 66 : 626A - 626A
  • [47] VARIANTS ASSOCIATED WITH VITAMIN D METABOLISM AND PROGRESSION TO HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C: DBGAP DATA FROM HALT-C TRIAL
    De Azevedo, L. A.
    Matte, U. D. S.
    Silveira, T. R.
    Alvares-da-Silva, M. R.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S334 - S334
  • [48] Positive impact of antiviral therapy on the long term outcome of chronic hepatitis C patients with cirrhosis
    Cardoso, Ana C.
    Moucari, Rami
    Boyer, Nathalie
    Asselah, Tarik
    Laatar, Asma
    Ripault, Marie-Pierre
    Martinot-Peignoux, Michele
    Maylin, Sarah
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 346A - 346A
  • [49] Treatment With Statins Reduces Liver Cancer Risk In Patients With Chronic Hepatitis C
    Nyberg, Anders H.
    Sadikova, Ekaterina
    Shi, Jiaxiao
    Cheetham, T. Craig
    Chiang, Kevin
    Younossi, Zobair M.
    Nyberg, Lisa M.
    HEPATOLOGY, 2015, 62 : 1079A - 1080A
  • [50] Portal hypertensive gastropathy is prevalent amongst chronic hepatitis C non-responders with bridging fibrosis and early cirrhosis: Results from the HALT-C trial.
    Fontana, RJ
    Sanyal, AJ
    Wright, E
    Di Bisceglie, A
    HEPATOLOGY, 2003, 38 (04) : 294A - 294A
12345